AAADV-ASCO-CDDF workshop to examine cancer prevention strategies in 2023

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Globally, about 18 million people will be diagnosed with cancer and approximately 10 million people will die from cancer this year. Between 30–50% of these cancer cases are potentially preventable today, a fact that highlights that prevention remains one of the most effective and cost-effective long-term strategies to reduce the global cancer burden. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
H. Kim Lyerly, MD
George Barth Geller Distinguished Professor of Immunology, Professor of surgery, immunology, and pathology, Duke University School of Medicine
Renzo Canetta, MD
Former vice president, Global R&D oncology policy, Bristol-Myers Squibb Research and Development; Board member, Leukemia & Lymphoma Society
Philip E. Castle, PhD, MPH
Director, Division of Cancer Prevention, National Cancer Institute
Lisa M. McShane, PhD
Associate director, Division of Cancer Treatment and Diagnosis, National Cancer Institute
Richard L. Schilsky, MD
Professor emeritus, University of Chicago; Former chief medical officer, American Society of Clinical Oncology; Board chair, Reagan-Udall Foundation for FDA
Table of Contents

YOU MAY BE INTERESTED IN

Recently, HHS Secretary Robert F. Kennedy Jr. posted a video montage featuring himself shirtless in jeans, working out with Kid Rock. The duo is in a blue-lit grotto with a cold plunge and sauna. Set to Kid Rock’s “Bawitdaba” and intercut with a selection of patriotic imagery, the video ends with the two men in a hot tub, chugging what appears to be milk.
H. Kim Lyerly, MD
George Barth Geller Distinguished Professor of Immunology, Professor of surgery, immunology, and pathology, Duke University School of Medicine
Renzo Canetta, MD
Former vice president, Global R&D oncology policy, Bristol-Myers Squibb Research and Development; Board member, Leukemia & Lymphoma Society
Philip E. Castle, PhD, MPH
Director, Division of Cancer Prevention, National Cancer Institute
Lisa M. McShane, PhD
Associate director, Division of Cancer Treatment and Diagnosis, National Cancer Institute
Richard L. Schilsky, MD
Professor emeritus, University of Chicago; Former chief medical officer, American Society of Clinical Oncology; Board chair, Reagan-Udall Foundation for FDA

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login